Skip to main content
International Journal of Ophthalmology logoLink to International Journal of Ophthalmology
. 2022 Aug 18;15(8):1249–1253. doi: 10.18240/ijo.2022.08.04

Atypical Adams-Oliver syndrome with typical ocular signs of familial exudative vitreoretinopathy

En-Zhong Jin 1, Lyu-Zhen Huang 1, Ming-Wei Zhao 1, Hong Yin 1
PMCID: PMC9358197  PMID: 36017054

Abstract

AIM

To report an atypical Adams-Oliver syndrome (AOS) family with typical ocular signs of familial exudative vitreoretinopathy (FEVR).

METHODS

A patient with visible avascular area and obvious non-perfusion zone in the peripheral retina with systemic signs of AOS was reported. Familial and personal characteristics were collected for the patient and his sister. Gene sequencing and ophthalmic examinations including fluorescein angiography were all performed for the whole family.

RESULTS

Two novel mutations of DOCK6 (c.1396C>T and c.4796G>A) were identified in the proband and his family, and two compound heterozygous mutations were revealed in the proband and his sister. The patient and his sister showed physical deformities and mental abnormalities while FEVR mimicking retinal disorder can also be defined. No remarkable ocular or systemic abnormality can be observed for their parents. Peripheral retinal non-perfusion area, obvious abnormal vascularization or even retinal fold were observed in the proband and his sister, while only small avascular zone was identified for their parents.

CONCLUSION

This is the first genetic authenticated AOS case mimicked as FEVR with genetic sequencing of a family. For the patients with ocular phenotype of FEVR, further examination should be performed if the systemic or mental abnormalities exist.

Keywords: Adams-Oliver syndrome, familial exudative vitreoretinopathy, gene sequencing, DOCK6, mutation

INTRODUCTION

Adams-Oliver syndrome (AOS) is a rare inherited condition first described in 1945[1]. As a multiple malformation syndrome, AOS was characterized by a combination of aplasia cutis congenita (ACC) and variable degree of transverse limb defects[1]. Several genes associated with AOS including DOCK, ARHGAP31, EOGT, RBPJ, and NOTCH have been reported in the past decade[2][10]. In previous studies, the systemic phenotype within families of AOS may range from no obvious clinical manifestations in mutation carriers to severe multiple-system anomalies that can even result in miscarriage or stillbirth[1].

The AOS associated with ocular findings is rarely reported especially for the patients initially diagnosed in Ophthalmology Department. Almost all reports associated with ocular disorders were cases. In a previous literature, a female AOS case with bilateral congenital cataract was reported[3]. In another report, a case of AOS mimicked as familial exudative vitreoretinopathy (FEVR) had been reported recently, but genetic testing was not performed in this single case[11]. In 2012, an AOS case presenting retinal findings consistent with ischemic-proliferative retinopathy had also been reported[12]. Since AOS was found to be associated with several ocular disorders and few cases have already been reported, the relationship between AOS and ocular diseases worth further discussion.

In our present report, a family of AOS with ocular signs of FEVR was identified according to the clinical and genetic findings with DOCK6 mutation. The ophthalmic examinations and gene sequencing were performed for the patient, his elder sister and their parents.

MATERIALS AND METHODS

Ethical Approval

This study was approved by the Ethical Review Committee of Peking University People's Hospital (Beijing, China), which was conducted in accordance with the Declaration of Helsinki. Written informed consent for genetic testing and medical photograph collection was obtained from the parents.

Patients

A 5-year-old boy initially diagnosed with FEVR and found to have AOS according to the systemic situation, family history and gene sequencing was described. The individual and family investigation were performed. All family members of the proband boy including the parents and his 10-year-old sister were included in the present study and underwent ocular and genetic examinations for further analysis.

Ophthalmic Examinations

Ophthalmologic examination was performed with a standard protocol including best-corrected visual acuity (BCVA), slit-lamp examination, binocular indirect ophthalmoscope fundus examination, ultra-wide-field fundus photography and fluorescein angiography (FA; Optos Daytona, Optos PLC, Dunfermline, UK). All the examination data was collected along with the data of medical history. All the digital images of fundus and FA were blinded reviewed by two experienced ophthalmologists (Yin H and Jin EZ).

Sequencing

Whole exome sequencing was performed to characterize mutations for the proband boy and all his family members. Peripheral blood samples were obtained for the gene sequencing and sent to an external service to be sequenced.

RESULTS

The 5-year-old boy was found to have abnormal eye position and slightly mental retardation from birth according to his parents' discription. No physical deformitie and mental abnormalities existed among his parents. For further family members' investigation, his 10-year-old sister previously defined as retinal detachment and clinically diagnosed with FEVR. She was found to have poor vision, esotropia, blepharophimosis, upward of external eye corner, mild mental retardation and left hemiplegia.

The boy born at full-term with birth weight of 3000 g, and no special prenatal history was recorded. The rough visual acuity of the boy was 20/80 for both eyes with poor cooperation. Non-contact intraocular pressure was 17 mm Hg and 16 mm Hg for right and left eye, respectively. The cycloplegic refraction was measured as follows: -0.25 D for the right eye and -4.00 D for the left eye. No obvious abnormalities can be observed for the examination of the anterior segment of the eyes. For the binocular indirect ophthalmoscope fundus examination, normal boundary and color of the optic discs can be showed, while the avascular area was visible in the periphery retina. Ultra-wide-field FA examination was performed for the patient and obvious non-perfusion in the peripheral retina can be defined. Abnormal vessels can be observed at the junction of vascular and avascular retina though no leakage was identified (Figure 1).

Figure 1. Fundus photograph and fluorescein angiogram of the patient.

Figure 1

A, B: Fundus photograph of the patient showing avascular zone of the temporal retina; C, D: Fluorescein angiogram of the patient showing peripheral retinal nonperfusion.

Fundus color photographs and FA images were also collected for the boy's elder sister and parents. For the sister, significant peripheral retinal detachment can be observed in both eyes with temporal retinal folds originating from the optic disc, and the temporal retina was gray-white with hyperpigmentation sounded. FA examination showed peripheral retinal non-perfusion area and abnormal vascularization including tortuous veins, arteriovenous shunt, abnormal anastomosis. Retinal atrophy and hyperpigmentation can also be identified in fluorescein angiogram (Figure 2).

Figure 2. Fundus photograph and fluorescein angiogram of the patient's sister.

Figure 2

A, B: Fundus photograph of the patient's sister showing retinal fold involving macular, retinal atrophy, temporal retinal detachment and obvious pigmentation around; C, D: Fluorescein angiogram of the patient's sister depicting focal abnormal hyperfluorescence and peripheral nonperfusion.

For their parents, the FA examinations were also performed. Only avascular zone and abnormal anastomosis at the vascular-avascular junction can be identified for them and both of them can reached a BCVA of 20/20. Meanwhile, no physical deformitie and mental abnormalities existed among the parents.

The genetic sequencing was performed for the whole family and the results indicated that the children (both the boy and his sister) had two compound heterozygous mutations (c.1396C>T p.R466X, c.4796G>A p.W1599X) in the gene DOCK6 associated with AOS type 2, and the family verification results showed the two heterozygous mutations were originated from their father and mother, respectively. Pedigrees of the family and sanger confirmation of the identified DOCK6 variants in proband with family members are shown in Figure 3.

Figure 3. Pedigrees of the family with mutations in this study and the chromatograms of c.4796G>A and c.1396C>T in the proband and his family.

Figure 3

A-E: Chromatograms of c.4796G>A; F-J: Chromatograms of c.1396C>T. A, F: Reference sequences; E, J: Sequences of the proband; B, G: Sequences of the proband's sister; C, H: Sequences of the proband's father; D, I: Sequences of the proband's mother. B, C and E showing c.4796G>A existed in the whole family except the mother; G, I and J showing c.1396C>T existed in the whole family except the father.

DISCUSSION

AOS was not frequently reported in patients with ocular disorders though some isolated cases had been described associated with congenital cataract and retinal findings[12][18]. In our case, we described a family of AOS with all the members showing retinal signs similar to FEVR and DOCK6 mutations. To the best of our knowledge, this is the first report of AOS family identified by gene mutations with mimicking FEVR retinal findings.

For the previous reports, the retinal fold with or without retinal detachment had been reported in AOS patients, and the retinal folds involving the macular was also described in one case[12],[19]. A seven-week-old full-term infant within normal birth weight clinically diagnosed with AOS with ocular signs similar to FEVR was reported[11]. While no remarkable change existed in anterior segment, a radial falciform retinal fold extending from the macula to temporal periphery can be defined in this case. Significant preretinal fibrous proliferation can be noted, but no neovascularization or exudation were observed, and no ophthalmic examination was performed for the parents and three male siblings of the infant[11]. In our case, the whole family underwent gene sequencing and ophthalmic examinations, and genetic mutations can be identified accurately. Retinal detachment accompanied by retinal fold can also be found in the sister, along with poor vision, mild mental retardation and left hemiplegia. The ocular and systemic disorders of the sister confirmed by the genetic sequencing can further assist the diagnosis of AOS for the whole family. In this case, FEVR-like fundus and fluorescein angiogram can be observed in all family members. Despite the presence of FEVR-like changes existed, they were generally quiet. No obvious peripheral leakage or retinal traction can be observed, and the boy was only asked for closely and regular follow-up without treatment.

In this case, the parents of the boy showed no obvious ocular symptoms or signs, but the boy showed slightly lower intelligence, poor vision, mild esotropia and large non-perfusion zone at the temporal retina, which suggesting FEVR-like fundus changes. For the family history, it was found that the child's sister had a history of retinal detachment with retinal fold in both eyes. Fundus examinations showed obvious retinal folds in both eyes, with small palpebral fissure, esotropia, raised outer corner of the eye, right hand penetrating palm, high muscle tension, mild hemiplegia of the left limb, etc. There are many similarities between these manifestations and the previously reported systemic and ocular signs of AOS[1].

Basing on the ocular and systemic manifestations of the boy and his sister, a whole-exome sequencing analysis of the single-gene disease was performed on the whole family. On one hand, further clarification whether there are FEVR-related genetic changes were performed, and on the other hand, it is also analyzed whether there was genetic mutation associated with AOS. The sequencing revealed that the proband had two heterozygous mutations (c.1396C>T p.R466X, c.4796G>A p.W1599X) in DOCK6 which is associated with the AOS type 2. Though the variant in DOCK6 was reported to be associated with AOS type 2 before, these two novel missense mutations identified in this study had not been previously registered in the Ensembl database (http://www.ensembl.org/index.html) or the Human Gene Mutation Database (HGMD, http://www.hgmd.cf.ac.uk/ac/index.php)[10]. And the compound heterozygous mutations of them were found to be associated with the AOS proband. The further family verification results showed that the two heterozygous mutations came from their parents respectively and were compound heterozygous mutations. The sister also carries the two compound heterozygous mutations. As truncating mutations, the two novel missense mutations show high potential pathogenicity. Our findings expand the mutational spectrum of DOCK6 and suggest that the two compound heterozygous mutations of DOCK6 is associated with AOS.

As we all know, AOS was first reported in 1945, mainly manifested as scalp defects and varying degrees of limb defects[1]. The AOS syndrome can be inherited in autosomal dominant manner in most cases, and in autosomal recessive manner for some cases (EOGT and DOCK6 gene mutations)[2][5]. The underlying pathological mechanism of AOS is considered as a congenital vascular disease that may involve multiple systems such as the cardiovascular system, brain, liver, lung, eyes and skin[6]. In the past, few reports about AOS related to ocular disorders, especially for retinal manifestations[11]. The insufficient evidence between AOS and retinal disorders like FEVR made the present study more meaningful. But the limitations of our study can not be ignored. First, only one family of AOS mimicked FEVR was included which may reduce the persuasion, more families or cases should be collected and combined analyzed. Second, as a report of family case, no functional validation was performed even though two novel mutations were found. Third, the ocular signs of FEVR of the proband and his sister was typical while the AOS signs of them were atypical, but the genetic sequencing can provide most strong evidence.

As an inherited retinal disorder characterized by abnormal development of retinal vasculature, FEVR was thought to be associated with Wnt signaling pathway[20][21]. Several genes including NDP, FZD4, LRP5, and TSPAN12 had been found to be associated with FEVR in previous studies[22][26]. On the other hand, these genes were also identified in atypical retinopathy of prematurity (ROP) patients[27][28]. The Wnt signaling pathway may play a common pathological role in them, which is a major role for the development of retinal vascular. According to the whole-exome sequencing analysis, no special mutations of these genes can be found in our present family case, which did not support the relationship between AOS and Wnt signaling pathway. Since no association between FEVR and DOCK6 had been identified before, and the RBPJ and NOTCH involved in the Notch signaling pathway were found to play a crucial role in developing blood vessel walls, the pathogenesis of AOS may be different with FEVR[19],[29][30]. Although a case of AOS with similar changes mimicking FEVR diagnosed basing on clinical systemic characteristics has been reported, the present case is the first confirmed family case basing on genetic sequencing. Our report provides information on genetic mutations and clinical features to assist the ophthalmologists in recognizing AOS patients. Also, this family case can help us further understanding the ocular manifestations of AOS. It can be defined that the ocular phenotype of AOS may mimic that of FEVR. The patients diagnosed with AOS should be further evaluated for the retinal vasculopathy by fundus examinations including fluorescein angiography to make sure whether specific treatment was required. And the FEVR patients should also be carefully evaluated for the potential possibility of suffering from AOS.

Acknowledgments

Authors' contributions: Jin EZ: Project development, data management and analysis, manuscript writing and editing; Huang LZ: Data analysis, manuscript editing; Zhao MW: Manuscript editing; Yin H: Project development, manuscript writing and editing.

Foundation: Supported by the National Natural Science Foundation of China (No.81800850).

Conflicts of Interest: Jin EZ, None; Huang LZ, None; Zhao MW, None; Yin H, None.

REFERENCES

  • 1.Alsulaiman AM, Alsulaiman HM, Almousa A, Alsulaiman SM. Adams oliver syndrome: a mimicker of familial exudative vitreoretinopathy. Am J Ophthalmol Case Rep. 2020;19:100715. doi: 10.1016/j.ajoc.2020.100715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dedania VS, Moinuddin O, Lagrou LM, Sathrasala S, Cord Medina FM, del Monte MA, Chang EY, Bohnsack BL, Besirli CG. Ocular manifestations of cutis marmorata telangiectatica congenita. Ophthalmol Retina. 2019;3(9):791–801. doi: 10.1016/j.oret.2019.03.025. [DOI] [PubMed] [Google Scholar]
  • 3.Fayol L, Garcia P, Denis D, Philip N, Simeoni U. Adams-Oliver syndrome associated with cutis marmorata telangiectatica congenita and congenital cataract: a case report. Am J Perinatol. 2006;23(3):197–200. doi: 10.1055/s-2006-934099. [DOI] [PubMed] [Google Scholar]
  • 4.Hassed S, Li SB, Mulvihill J, Aston C, Palmer S. Adams-Oliver syndrome review of the literature: refining the diagnostic phenotype. Am J Med Genet A. 2017;173(3):790–800. doi: 10.1002/ajmg.a.37889. [DOI] [PubMed] [Google Scholar]
  • 5.Hassed SJ, Wiley GB, Wang SF, Lee JY, Li SB, Xu WH, Zhao ZJ, Mulvihill JJ, Robertson J, Warner J, Gaffney PM. RBPJ mutations identified in two families affected by Adams-oliver syndrome. Am J Hum Genet. 2012;91(2):391–395. doi: 10.1016/j.ajhg.2012.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Küster W, Lenz W, Kääriäinen H, Majewski F. Congenital scalp defects with distal limb anomalies (Adams-Oliver syndrome): report of ten cases and review of the literature. Am J Med Genet. 1988;31(1):99–115. doi: 10.1002/ajmg.1320310112. [DOI] [PubMed] [Google Scholar]
  • 7.Cerikan B, Schiebel E. Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases. Small Gtpases. 2019;10(3):210–217. doi: 10.1080/21541248.2017.1297882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schröder KC, Duman D, Tekin M, Schanze D, Sukalo M, Meester J, Wuyts W, Zenker M. Adams-Oliver syndrome caused by mutations of the EOGT gene. Am J Med Genet. 2019;179(11):2246–2251. doi: 10.1002/ajmg.a.61313. [DOI] [PubMed] [Google Scholar]
  • 9.Huang SQ, Yang L, Zhao LQ, Xu R, Wu YR. Novel In-frame deletion mutation in NOTCH1 in a Chinese sporadic case of Adams-oliver syndrome. DNA Cell Biol. 2020;39(5):783–789. doi: 10.1089/dna.2019.5200. [DOI] [PubMed] [Google Scholar]
  • 10.Alzahem T, Alsalamah AK, Mura M, Alsulaiman SM. A novel variant in DOCK6 gene associated with Adams-Oliver syndrome type 2. Ophthalmic Genet. 2020;41(4):377–380. doi: 10.1080/13816810.2020.1776339. [DOI] [PubMed] [Google Scholar]
  • 11.Orstavik KH, Strömme P, Spetalen S, Flage T, Westvik J, Vesterhus P, Skjeldal O. Aplasia cutis congenita associated with limb, eye, and brain anomalies in sibs: a variant of the Adams-Oliver syndrome? Am J Med Genet. 1995;59(1):92–95. doi: 10.1002/ajmg.1320590118. [DOI] [PubMed] [Google Scholar]
  • 12.Peralta-Calvo J, Pastora N, Casa-Ventura YG, Hernandez-Serrano R, Abelairas J. Peripheral ischemic retinopathy in Adams-oliver syndrome. Arch Ophthalmol. 2012;130(8):1078–1080. doi: 10.1001/archophthalmol.2012.531. [DOI] [PubMed] [Google Scholar]
  • 13.Prothero J, Nicholl R, Wilson J, Wakeling EL. Aplasia cutis congenita, terminal limb defects and falciform retinal folds: confirmation of a distinct syndrome of vascular disruption. Clin Dysmorphol. 2007;16(1):39–41. doi: 10.1097/MCD.0b013e328010b81c. [DOI] [PubMed] [Google Scholar]
  • 14.Shaheen R, Aglan M, Keppler-Noreuil K, et al. Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-oliver syndrome. Am J Hum Genet. 2013;92(4):598–604. doi: 10.1016/j.ajhg.2013.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Shaheen R, Faqeih E, Sunker A, Morsy H, Al-Sheddi T, Shamseldin HE, Adly N, Hashem M, Alkuraya FS. Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet. 2011;89(2):328–333. doi: 10.1016/j.ajhg.2011.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Southgate L, Machado RD, Snape KM, et al. Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies. Am J Hum Genet. 2011;88(5):574–585. doi: 10.1016/j.ajhg.2011.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Naravane AV, Belin PJ, Bhambhani V, Quiram PA. Adams-Oliver syndrome: a case of bilateral progressive ischemic maculopathy. J Am Assoc Pediatr Ophthalmol Strabismus. 2020;24(3):186–188. doi: 10.1016/j.jaapos.2020.03.007. [DOI] [PubMed] [Google Scholar]
  • 18.Meyer BI, Williams PJ, Hanif AM, Lenhart PD, Hubbard GB. Proliferative retinopathy in a 13-year-old with Adams-oliver syndrome. Retin Cases Brief Rep. 2020:2020 Dec 7. doi: 10.1097/ICB.0000000000001073. Online ahead of print. [DOI] [PubMed] [Google Scholar]
  • 19.Stittrich AB, Lehman A, Bodian DL, et al. Mutations in NOTCH1 cause Adams-oliver syndrome. Am J Hum Genet. 2014;95(3):275–284. doi: 10.1016/j.ajhg.2014.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang ZX, Liu CH, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res. 2019;70:110–133. doi: 10.1016/j.preteyeres.2018.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tauqeer Z, Yonekawa Y. Familial exudative vitreoretinopathy: pathophysiology, diagnosis, and management. Asia Pac J Ophthalmol (Phila) 2018;7(3):176–182. doi: 10.22608/APO.201855. [DOI] [PubMed] [Google Scholar]
  • 22.Wang ZR, Chen CL, Sun LM, Zhang AY, Liu CX, Huang L, Ding XY. Symmetry of folds in FEVR: a genotype-phenotype correlation study. Exp Eye Res. 2019;186:107720. doi: 10.1016/j.exer.2019.107720. [DOI] [PubMed] [Google Scholar]
  • 23.Tang M, Sun LM, Hu A, Yuan ME, Yang Y, Peng XN, Ding XY. Mutation spectrum of the LRP5, NDP, and TSPAN12 genes in Chinese patients with familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2017;58(13):5949. doi: 10.1167/iovs.17-22577. [DOI] [PubMed] [Google Scholar]
  • 24.Tian T, Chen CL, Zhang X, Zhang Q, Zhao PQ. Clinical and genetic features of familial exudative vitreoretinopathy with only-unilateral abnormalities in a Chinese cohort. JAMA Ophthalmol. 2019;137(9):1054–1058. doi: 10.1001/jamaophthalmol.2019.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Xiao HT, Tong YN, Zhu YX, Peng M. Familial exudative vitreoretinopathy-related disease-causing genes and norrin/β-catenin signal pathway: structure, function, and mutation spectrums. J Ophthalmol. 2019;2019:5782536. doi: 10.1155/2019/5782536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Li JK, Li YA, Zhang X, Chen CL, Rao YQ, Fei P, Zhang Q, Zhao PQ, Li J. Spectrum of variants in 389 Chinese probands with familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2018;59(13):5368–5381. doi: 10.1167/iovs.17-23541. [DOI] [PubMed] [Google Scholar]
  • 27.Rathi S, Jalali S, Musada GR, Patnaik S, Balakrishnan D, Hussain A, Kaur I. Mutation spectrum of NDP, FZD4 and TSPAN12 genes in Indian patients with retinopathy of prematurity. Br J Ophthalmol. 2018;102(2):276–281. doi: 10.1136/bjophthalmol-2017-310958. [DOI] [PubMed] [Google Scholar]
  • 28.Li YA, Li JK, Zhang X, Peng J, Li J, Zhao PQ. Identification of gene mutations in atypical retinopathy of prematurity cases. J Ophthalmol. 2020;2020:4212158. doi: 10.1155/2020/4212158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hurtado C, Safarova A, Smith M, et al. Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Sci Rep. 2019;9(1):10811. doi: 10.1038/s41598-019-46948-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Giaimo BD, Gagliani E, Kovall R, Borggrefe T. Transcription factor RBPJ as a molecular switch in regulating the Notch response. Adv Exp Med Biol. 2021;1287:9–30. doi: 10.1007/978-3-030-55031-8_2. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Ophthalmology are provided here courtesy of Press of International Journal of Ophthalmology

RESOURCES